MedPath

Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB)

Not Applicable
Conditions
Covid19
Interventions
Other: nasopharyngeal swabbing procedure (self swabbing first)
Other: nasopharyngeal swabbing procedure (conventionnal swabbing first)
Registration Number
NCT04831853
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Self-swabbing requires less personal protective equipment and could allow to test more people and even to do quick self-diagnosis if antigenic tests are available.

In a preliminary study on 190 medical students, the investigators have shown that self and conventional swabbing were identically well-accepted with equivalent level of pain and discomfort induced by swabbing. In a sub-group of this sample, the investigators have shown that the quality of the 2 sampling methods were equivalent.

The goal of this large study in the general population is to confirm these findings in an adequately powered study. Such results would allow to develop self-swabbing for large screening campaigns and eventually self-diagnosis using antigenic tests.

Detailed Description

All consecutive subjects coming to the 2 dedicated centers for COVID-19 screening in Clermont-Ferrand University hospital (one for medical students and one for the general population) will be asked to be included in the present study. They will be randomly assigned to either supervised self-swabbing followed by conventional swabbing led by a healthcare professional or the other way round.

All the subjects will have to complete a brief questionnaire including demographical characteristics (age, sex, height, weight, eye color), potential symptoms (asthenia, fever, anosmia...) anticipated pain and discomfort and previous nasopharyngeal swabbing experience. Pain, discomfort and overall acceptability of the procedure will be completed just after completion of the swabbing.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Any subject coming for nasopharyngeal swabbing for SARS-CoV-2 screening
  • Fluent in French (both oral and written)
  • Able to give an eclaired consent
Exclusion Criteria
  • Contra-indication to nasopharyngeal swabbing
  • Refusal to participate
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supervised self-swabbing followed by conventional swabbingnasopharyngeal swabbing procedure (self swabbing first)the subjects will first benefit from a 5 minutes explanation on how to perform self-swabbing and will then performed the swabbing under the supervision of a trained healthcare professional
Conventional swabbing followed by supervised self-swabbingnasopharyngeal swabbing procedure (conventionnal swabbing first)the subject will undergo conventional nasopharyngeal swabbing performed by a trained healthcare professional first.
Primary Outcome Measures
NameTimeMethod
Non-inferiority of self-swabbing compared to conventional swabbing concerning diagnosis sensitivity5 minutes after the end of the procedure of nasopharyngeal swabbing

assessed using consistency of COVID-19 RT-PCR results for both sampling modalities (Self- swabbing versus conventional-swabbing). If non-inferiority is confirmed on this criterion, pain will be tested.

Secondary Outcome Measures
NameTimeMethod
Richness assessment for respiratory cellsDay 0

Ct value of beta-globin gene

Non-inferiority of self-swabbing compared to conventional swabbing concerning acceptability5 minutes after the end of the procedure of nasopharyngeal swabbing

assessed using a Numerical Rating Scale (0 indicating that the procedure is not acceptable at all and 10 that the procedure is perfectly well accepted).

Correlation between body mass index and swabbing-induced pain5 minutes after the end of the procedure

symptoms self-reported by the subject and pain score on numeric rating scale (0 to 10; higher scores meaning more pain)

Non-inferiority of self-swabbing compared to conventional swabbing concerning pain5 minutes after the end of the procedure of nasopharyngeal swabbing

assessed using a Numerical Rating Scale (0 indicating no pain and 10 the worst imaginable pain). If non-inferiority is confirmed on this criterion, discomfort will be tested

Correlation between symptoms (fever, headache, asthenia, anosmia, agueusia, cough, dyspnea, muscle pain, sore throat, diarrhea) and swabbing-induced pain5 minutes after the end of the procedure

symptoms self-reported by the subject and pain score on numeric rating scale (0 to 10; higher scores meaning more pain)

Correlation between anticipated pain and actual pain5 minutes after the end of the procedure

anticipated and actual pain self-reported on numeric rating scale (0 to 10; higher scores meaning more pain)

Correlation between anticipated discomfort and actual discomfort.5 minutes after the end of the procedure

anticipated and actual discomfort self-reported on numeric rating scale (0 to 10; higher scores meaning more pain)

Correlation between age, sex and swabbing-induced pain5 minutes after the end of the procedure

Score on the pain numeric rating scale (0 to 10; higher scores meaning more pain)

Correlation between eye color and swabbing-induced pain5 minutes after the end of the procedure

Eye-color self-reported by the subject on a validated 14 item scale and pain score on the numeric rating scale (NRS) (0 to 10; higher scores meaning more pain)

Correlation between eye color and swabbing-induced discomfort5 minutes after the end of the procedure

Eye-color self-reported by the subject on a validated 14 item scale and discomfort score on numeric rating scale (0 to 10; higher scores meaning more discomfort)

Non-inferiority of self-swabbing compared to conventional swabbing concerning pain discomfort5 minutes after the end of the procedure of nasopharyngeal swabbing

assessed using a Numerical Rating Scale (0 indicating no discomfort and 10 the worst imaginable discomfort). If non-inferiority is confirmed on this criterion, acceptability will be tested

Trial Locations

Locations (1)

CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath